RARα Inhibitors

Common RARα Inhibitors include, but are not limited to BMS 493 CAS 215030-90-3, AM 580 CAS 102121-60-8, TTNPB CAS 71441-28-6, ER 50891 CAS 187400-85-7 and Bexarotene CAS 153559-49-0.

RARα inhibitors belong to a specific chemical class of compounds designed to target and inhibit the activity of the Retinoic Acid Receptor alpha (RARα). RARα is a nuclear hormone receptor and a member of the retinoic acid receptor family, which plays a crucial role in mediating the cellular effects of retinoic acid (RA), a derivative of vitamin A. Upon binding to RA, RARα forms a complex with retinoid X receptor (RXR) and regulates the transcription of target genes involved in various biological processes, such as cell differentiation, development, and homeostasis.

RARα inhibitors work by specifically targeting the RARα protein, disrupting its ability to bind to RA or interact with RXR, thus modulating its transcriptional activity. By doing so, these inhibitors may influence the expression of downstream target genes and the cellular responses mediated by RARα, affecting processes like cell differentiation and tissue development. Research into RARα and its inhibitors is ongoing to unravel their precise mechanisms of action and explore their implications in cellular physiology. The study of RARα inhibitors represents an intriguing area of research, contributing to a deeper understanding of the intricate mechanisms that govern retinoic acid signaling and its impact on cellular processes.